NCT00882219View on ClinicalTrials.gov

Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implanted in the Treatment of Restenosis in Non-coated Metallic Stent (BMS In-stent Restenosis) During a 2 Year Clinical Follow-up Period

PHASE3CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

March 31, 2011

Study Completion Date

July 31, 2012

Conditions
Coronary Restenosis
Interventions
DEVICE

Xience V®

Placement of a Xience V® stent within a restenosed bare metal stent.

Trial Locations (1)

31403

Hopital de Rangueil - Chu, Toulouse

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT00882219 - Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implanted in the Treatment of Restenosis in Non-coated Metallic Stent (BMS In-stent Restenosis) During a 2 Year Clinical Follow-up Period | Biotech Hunter | Biotech Hunter